ATRX and central nervous system cancer: To assess whether p53 alterations cooperate with ATRX loss in promoting ALT in adult glioma, we overexpressed a dominant-negative p53 (TP53R273H) in MOG-G-UVW ATRXKO clones (Part A of S4 Fig).